Z

Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332

Watchlist Manager
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Watchlist
Price: 10.28 CNY -0.87% Market Closed
Market Cap: 10.2B CNY
Have any thoughts about
Zhejiang Xianju Pharmaceutical Co Ltd?
Write Note

Zhejiang Xianju Pharmaceutical Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Xianju Pharmaceutical Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Accounts Payable
ÂĄ324.9m
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
1%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accounts Payable
ÂĄ163.8m
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accounts Payable
ÂĄ470.9m
CAGR 3-Years
23%
CAGR 5-Years
13%
CAGR 10-Years
19%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accounts Payable
ÂĄ1.4B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
15%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accounts Payable
ÂĄ4.5B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
7%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accounts Payable
ÂĄ307.9m
CAGR 3-Years
65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Xianju Pharmaceutical Co Ltd
Glance View

Market Cap
10.2B CNY
Industry
Pharmaceuticals

In the heart of eastern China, Zhejiang Xianju Pharmaceutical Co., Ltd. stands as a testament to China's evolving pharmaceutical prowess. Founded in 1972, Xianju Pharmaceutical has carved out a niche in the global healthcare market by specializing in the production of corticosteroids and hormone APIs (Active Pharmaceutical Ingredients). What sets Xianju apart is its relentless focus on research and development, enabling the company to produce a wide array of steroid and hormone products that cater to both domestic and international markets. The innovation pipeline is fueled by a robust R&D team that ensures the company remains at the forefront of pharmaceutical advancements, allowing it to consistently meet the stringent quality standards expected in this highly regulated industry. The company's financial engine runs on its ability to manufacture these high-demand products efficiently and at scale, leveraging advanced technologies and integrated production processes. This operational efficiency provides Xianju a competitive edge in price stability and market reach. The revenue stream is diversified yet strategically concentrated on its core competencies, allowing Xianju to capitalize on rising global demands for hormone therapies and steroid-related medical treatments. By maintaining strong relationships with global partners and continuously expanding its distribution networks, Zhejiang Xianju Pharmaceutical not only sustains its profitability but also plays a critical role in shaping healthcare outcomes around the world. The company's growth trajectory suggests a finely balanced strategy that combines innovation, production excellence, and market expansion.

Intrinsic Value
17.51 CNY
Undervaluation 41%
Intrinsic Value
Price
Z

See Also

What is Zhejiang Xianju Pharmaceutical Co Ltd's Accounts Payable?
Accounts Payable
324.9m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Xianju Pharmaceutical Co Ltd's Accounts Payable amounts to 324.9m CNY.

What is Zhejiang Xianju Pharmaceutical Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
1%

Over the last year, the Accounts Payable growth was 4%. The average annual Accounts Payable growth rates for Zhejiang Xianju Pharmaceutical Co Ltd have been -4% over the past three years , 3% over the past five years , and 1% over the past ten years .

Back to Top